Cellular Therapies Promising in Advanced Synovial Sarcoma

(MedPage Today) -- Targeting NY-ESO-1 and MAGE-A4 with novel adoptive cellular therapies led to responses in at least a third of patients with recurrent or metastatic synovial sarcoma, findings from two phase I studies showed.
Among 45 patients...